Cerebrospinal fluid filtration in amyotrophic lateral sclerosis

European Journal of Neurology

Volumn 6, Issue 5, 1999, Pages 597-600

  Finsterer, Josef ^a,b   Mamoli, Bruno ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b NONE   (Austria)

Author keywords

Amyotrophic lateral sclerosis; Bulbar paralysis; CSF filtration; Liquorpheresis; Riluzole therapy

Indexed keywords

RILUZOLE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BICEPS BRACHII MUSCLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROMYOGRAM; FEMALE; FILTRATION; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TIBIALIS ANTERIOR MUSCLE; TREATMENT OUTCOME; ULNAR NERVE; VITAL CAPACITY;

EID: 0033380490     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.1999.650597.x     Document Type: Article

References (16)

1. Andrich J, Schimrigk S, Hoffmann U, Rother S, Meves S, Pöhlau D (1996). Short lasting improvement after treatment with cerebrospinal fluid filtration (CSFF) in two patients with sporadic amyotrophic lateral sclerosis (SSALS). J Neurol 243(suppl 2):95.
2. Chou SM (1997). Neuropathology of amyotrophic lateral sclerosis: new perspectives on an old disease. J Form Med Assoc 96:488-498.
3. Couratier P, Hugon J, Sindou P, Vallat JM, Dumas M (1993). Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/ kainate receptors. Lancet 341:265-268.
4. Enderby P, Crow F. (1996). Frenchay aphasia screening test: validity and comparability. Disabil Rehabil 18:238-240.
5. Finsterer J, Mamoli B, Fuglsang-Frederiksen A (1997). Peak- ratio interference pattern analysis in the detection of neuromuscular disorders. Electroencephalog Clin Neuroplysiol 105:379-384.
6. Heusslein R, Rother S, Trömel C, Wollinsky K-H, Schmutzhard E, Pöhlau D (1996). CSF filtration: scientific and clinical update. In: Anaesthesia, Pain, Intensive Care and Emergency Medicine editor A. Gullo. Springer, Milano, pp 627-638.
7. Hugon J (1996). ALS therapy: targets for the future. Neurology 47(suppl 4):S251-S254.
8. Ince PG, Lowe J, Shaw PJ (1998). Amyotrophic lateral sclerosis: current issues, classification, pathogenesis and molecular pathology. Neuropathol Appl Neuro 24:104-117.
9. LaBella V, Goodman JC, Appel SH (1997). Increased CSF glutamate following injection of ALS immunoglobulins. Neurology 48:1270-1272.
10. Norris FH, Calanchini PR, Fallat RJ, Panchari S, Jewett B (1974). The administration of Guanidine in amyotrophic lateral sclerosis. Neurology 24:721-728.
11. Pöhlau D, Schimrigk S, Andrich J, Hoffmann U, Ricks M, Meves S, Rother S, Przuntek H (1996). Funktionsverbesserungen durch Liquorfiltration bei Patienten mit sporadischer amyotropher Lateralsklerose. In: Arbeitstagung zur Neuro-intensivmedizin editors J. Treib, M. Stoll, R. Lindenmuth. Verlag Conrad und Bothner, Zweibrücken. p. 67.
12. Shahani N, Nalini A, GourieDevi M, Raju TR (1998). Reactive astrogliosis in neonatal rat spinal cord after exposure to cerebrospinal fluid from patients with amyotrophic lateral sclerosis. Experimental Neurology 149:295-298
13. Stevens A, Weller M, Wietholter H (1993). A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiat 56:361-364.
14. Tsuboi Y, Yamada T (1994). Increased concentration of C4d complement protein in CSF in amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiat 57:859-861.
15. Wollinsky KH, Hülser P-J, Brinkmeier H, Mehrkens H-H, Kornhuber H-H, Rüdel R (1994). Filtration of cerebrospinal fluid in acute inflammatory demyelinating polyneuropathy (Guillain-Barré Syndrome). Ann Med Interne 145:451-458.
16. World Federation of Neurology Group on Neuromuscular Diseases. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical Limits of Amyotrophic Lateral Sclerosis' Workshop Contributors (1994). El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 124:96-107.